Wellington, Feb 21 (IANS) New Zealand will bring back over-the-counter sales of cold and flu drugs in pharmacies by getting rid of unnecessary red tape.
This act allows New Zealanders greater freedom and choice to purchase effective cold and flu medicines, Xinhua news agency reported.
“Cold and flu medicines containing pseudoephedrine will be reclassified from prescription to restricted medicines, which will allow the public to purchase these medicines from a pharmacy without a prescription,” Associate Health Minister David Seymour said on Tuesday.
A bill amending the Misuse of Drugs Act, 1975, is being introduced and changes to the Medicines Regulations, 1984, are being made to reclassify pseudoephedrine.
Pseudoephedrine was banned because of fears it would be used for methamphetamine production, Seymour said, adding the gangs have far more effective ways of obtaining pseudoephedrine to manufacture methamphetamine which should be tackled instead.
“Alternative cold and flu medicines have been shown to be no more effective than a placebo. New Zealanders are being denied decent cold and flu medication, but the gangs are selling more methamphetamine than ever,” he said.
The use of these medicines will still be subject to a level of oversight as consumers will be required to purchase them directly from a pharmacist, Seymour said, adding restrictions on importing and exporting these medicines will also be retained.
Taking into account supply chains and the ability of companies to prepare products, it is expected the medication will be back on shelves in 2025.
Rhys Ponton of the School of Pharmacy at the University of Auckland said pseudoephedrine was removed from community pharmacy sales in 2011 due to concerns that it was used as a precursor to the manufacture of methamphetamine. However, the restriction on this precursor has not reduced the availability or stopped the use of methamphetamine in New Zealand as demonstrated by police and customs seizures data.
It is unclear if the return of pseudoephedrine will lead to changes in the criminal supply of methamphetamine, Ponton said, adding concerns from pharmacists surrounding potential security risks should be listened to, and any such events should be closely monitored.
–IANS
int/khz
Disclaimer
The information contained in this website is for general information purposes only. The information is provided by TodayIndia.news and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.
Through this website you are able to link to other websites which are not under the control of TodayIndia.news We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, TodayIndia.news takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
For any legal details or query please visit original source link given with news or click on Go to Source.
Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.
If you are not willing to accept this disclaimer then we recommend reading news post in its original language.
